Aldeyra Therapeutics to Participate in the Jefferies Global Healthcare Conference in London

Core Insights - Aldeyra Therapeutics, Inc. is focused on developing innovative therapies for immune-mediated diseases [1] Company Participation - Todd C. Brady, M.D., Ph.D., President and CEO of Aldeyra, will participate in a fireside chat at the 2025 Jefferies Global Healthcare Conference in London [1] - The discussion will be moderated by Clara Dong, Ph.D., Vice President of Biotechnology Equity Research [1]